A randomized, phase 1b study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of bleselumab, a fully human, anti-CD40 monoclonal antibody, in kidney transplantation
Titel:
A randomized, phase 1b study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of bleselumab, a fully human, anti-CD40 monoclonal antibody, in kidney transplantation
Auteur:
Vincenti, Flavio Klintmalm, Goran Yang, Harold Ram Peddi, V. Blahunka, Paul Conkle, Angela Santos, Vicki Holman, John
Verschenen in:
American journal of transplantation
Paginering:
Jaargang 20 () nr. 1 pagina's 172-180
Jaar:
2020
Inhoud:
Uitgever:
American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved.